Prospect Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Prospect Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Buy	+1,606	New	+$200K	0.13%	100
2025 Q1	–	Sell	-2,451	Closed	-$221K	–	124
2024 Q4	$221K	Hold	2,451	–	–	0.12%	105
2024 Q3	$242K	Sell	2,451 -250	-9%	-$24.6K	0.15%	90
2024 Q2	$250K	Hold	2,701	–	–	0.19%	66
2024 Q1	$256K	Buy	2,701 +230	+9%	+$21.3K	0.21%	64
2023 Q4	$221K	Buy	+2,471	New	+$184K	0.22%	64

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prospect Financial Services's XBI Position: Q1 2026 in Review

Prospect Financial Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 1,606 shares worth $205K. The stake represents 0.13% of the portfolio and ranks #100 among its holdings. This is a return to the name: Prospect Financial Services previously reported a position in XBI as recently as Q4 2024.

Prospect Financial Services first reported a position in XBI in Q4 2023 and has held it in 6 quarters since. The position peaked at $256K in Q1 2024. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Prospect Financial Services held 1,606 shares of State Street SPDR S&P Biotech ETF worth $205K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Prospect Financial Services position in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.13% of Prospect Financial Services's portfolio in Q1 2026, its #100 holding.
Prospect Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 6 quarters since.
Prospect Financial Services's State Street SPDR S&P Biotech ETF position peaked at $256K in Q1 2024.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Prospect Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.